Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anca Buzoianu

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Clujul Medical (1957)|November 4, 2015
Phenotypic differences in nebivolol metabolism and bioavailability in healthy volunteersCorina Briciu, Maria Neag, Dana Muntean, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 2, 2017
Investigation of a Potential Pharmacokinetic Interaction Between Nebivolol and Fluvoxamine in Healthy VolunteersAna-Maria Gheldiu, Laurian Vlase, Adina Popa, et al.
Experimental and Therapeutic Medicine|March 30, 2022
Basic cardiovascular risk assessment in naïve patients with colon cancerLiliana Radulescu, Lucretia Avram, Elena Buzdugan, et al.
Rheumatology International|December 17, 2013
Candidate's single-nucleotide polymorphism predictors of treatment nonresponse to the first anti-TNF inhibitor in ankylosing spondylitisRuxandra Schiotis, Alejandra Sánchez, Alejandro Escudero, et al.
Plos One|September 18, 2012
Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitisRuxandra Schiotis, Nerea Bartolomé, Alejandra Sánchez, et al.
Journal of Nanoscience and Nanotechnology|November 22, 2011
Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the ratHari Shanker Sharma, Dafin Fior Muresanu, Ranjana Patnaik, et al.
Biomarker Research|August 15, 2025
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myelomaDavid Kegyes, Anamaria Bancos, Adrian Bogdan Tigu, et al.
International Journal of Nanomedicine|March 2, 2016
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapyBobe Petrushev, Sanda Boca, Timea Simon, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Clujul Medical (1957)|November 4, 2015
Phenotypic differences in nebivolol metabolism and bioavailability in healthy volunteersCorina Briciu, Maria Neag, Dana Muntean, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|May 2, 2017
Investigation of a Potential Pharmacokinetic Interaction Between Nebivolol and Fluvoxamine in Healthy VolunteersAna-Maria Gheldiu, Laurian Vlase, Adina Popa, et al.
Experimental and Therapeutic Medicine|March 30, 2022
Basic cardiovascular risk assessment in naïve patients with colon cancerLiliana Radulescu, Lucretia Avram, Elena Buzdugan, et al.
Rheumatology International|December 17, 2013
Candidate's single-nucleotide polymorphism predictors of treatment nonresponse to the first anti-TNF inhibitor in ankylosing spondylitisRuxandra Schiotis, Alejandra Sánchez, Alejandro Escudero, et al.
Plos One|September 18, 2012
Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitisRuxandra Schiotis, Nerea Bartolomé, Alejandra Sánchez, et al.
Journal of Nanoscience and Nanotechnology|November 22, 2011
Superior neuroprotective effects of cerebrolysin in heat stroke following chronic intoxication of Cu or Ag engineered nanoparticles. A comparative study with other neuroprotective agents using biochemical and morphological approaches in the ratHari Shanker Sharma, Dafin Fior Muresanu, Ranjana Patnaik, et al.
Biomarker Research|August 15, 2025
Targeting degradation of IKZF1 and IKZF3 through modulation of the E3 ligase substrates in the context of cellular therapies for multiple myelomaDavid Kegyes, Anamaria Bancos, Adrian Bogdan Tigu, et al.
International Journal of Nanomedicine|March 2, 2016
Gold nanoparticles enhance the effect of tyrosine kinase inhibitors in acute myeloid leukemia therapyBobe Petrushev, Sanda Boca, Timea Simon, et al.
Pageof 2